DE   EN   ES   FR   IT   PT


medicalmeds.eu Endocrinology Polyendocrine adenomatosis

Polyendocrine adenomatosis


Description:


Family polyendocrine adenomatosis (SPEA) - the disease which is characterized by development of tumors in two and more closed glands, a thicket in Langerkhans's islands of a pancreas and epithelial body (a source - the main cells).


Symptoms of Polyendocrine adenomatosis:


Distinguish 3 SPEA types:
- Type I (Vyormer's syndrome, 131100, 1Ts13, MEN1 gene, R):): epithelial bodies, Langerkhans's islands of a pancreas and a hypophysis are involved
- The hyperparathyreosis arises approximately at 90% of patients (at a quarter from them - a hyperplasia of all epithelial bodies)
- Tumors of insular tissue of pancreas find at 80% of patients (as a rule, a gastrinoma, a glucagonoma or an insulinoma)
- Adenomas of a hypophysis observe in 65% of cases
- The stomach ulcers caused by pancreatic gastrinomy.
- Type II (Sippl's syndrome, #171400, 10qll.2, an oncogene of RET, [164761], R): [164761], it is necessary to suspect a disease at any relative of the patient having medullary cancer of a thyroid gland
- The medullary carcinoma of a thyroid gland is found in all patients
- Pheochromocytomas observe approximately at 40% of patients. Tumors are usually bilateral, sometimes malignant. In most cases manifestations of a pheochromocytoma arise later, than symptoms of cancer of thyroid gland
- The hyperplasia of epithelial bodies develops at 60% of patients.
- Type III (#162300, 10qll.2, RET oncogene, R)) regard as II option (sometimes designate the lib type, then Sippl's syndrome is designated as the IIA type)
- As well as at II SPEA, medullary cancer of a thyroid gland and a pheochromocytoma develops. The most characteristic signs: deformations of a skeleton and multiple neurinoma of mucous membranes
- SPEA III is shown at younger age (more often up to 20 years) and proceeds much more aggressively; earlier diagnosis is necessary.


Reasons of Polyendocrine adenomatosis:


The disease has a hereditary etiolgiya.


Treatment of Polyendocrine adenomatosis:


SPEA OF I
First of all it is necessary to eliminate a hyper parathyroid state. Gastrin secretion can be as a result reduced that favors to healing of stomach ulcers. The subtotal parathyroidectomy as the disease usually proceeds with a hyperplasia of all four glands is necessary. If the gipergastrinemiya and a peptic ulcer of a stomach do not respond to treatment, it is necessary to remove the tumor producing gastrin. If the tumor of a pancreas does not manage to be removed, and use of H2 blockers does not lead to healing of ulcers, carry out a resection of a stomach or a gastrectomy. Tumors of a hypophysis delete by a transsphenoidal hypophysectomy.

SPEA II
Medullary carcinoma of a thyroid gland (treatment is effective at a precancer stage [a hyperplasia S-kle-tok], the total thyroidectomy is shown). Pheochromocytoma or hyperplasia of a brain part of an adrenal gland: first of all carry out their treatment (to a thyroidectomy), otherwise when performing operation on a thyroid gland gipertenzionny crisis is possible. The hyperparathyreosis can be cured by a total thyroidectomy.

SPEA III. Therapy is similar to type II. As the type III proceeds especially aggressively, early and radical treatment is necessary.



Drugs, drugs, tablets for treatment of Polyendocrine adenomatosis:

  • Препарат Омепразол-Акри®.

    Омепразол-Акри®

    Stomach glands secretion the lowering means — the protonew pump inhibitor.

    JSC Chemical and Pharmaceutical Plant AKRIKHIN Russia

    6

  • Препарат Омепразол Сандоз 40 мг.

    Omeprazol Sandoz of 40 mg

    Antiulcerous means. Inhibitors of "the proton pump".

    Sandoz Gmbh (Sandoz Gmbh) Germany

  • Препарат Омепразол.

    Omeprazol

    Stomach glands secretion the lowering means — the protonew pump inhibitor.

    CJSC Kanonfarm production Russia

  • Препарат Омепразол капс. 0,02 г №3/10/20/30.

    Omeprazol капс. 0,02 g No. 3/10/20/

    Stomach glands secretion the lowering means — the protonew pump inhibitor.

    CJSC Severnaya Zvezda Russia

  • Препарат Омепразол.

    Omeprazol

    Means for treatment of the states connected with acidity disturbance. The antiulcerous means and means applied at a gastroesophageal reflux disease. Inhibitors of the proton pump.

    JSC Borisovsky Plant of Medical Supplies Republic of Belarus

  • Препарат Омез® Инста.

    Омез® Insta

    Stomach glands secretion the lowering means — the protonew pump inhibitor.

    Dr. Reddys Laboratories Ltd. (Dr. of Reddis Laboratoris Ltd.) India

  • Препарат Фамотидин-АКОС.

    Famotidin-AKOS

    Stomach glands secretion the lowering means - H2-histamine of receptors a blocker.

    JSC Sintez Russia

  • Препарат Фамотидин.

    Famotidine

    Antiulcerous drugs. H2 - antihistamines.

    SC Balkan Pharmaceuticals SRL (Balkans Pharmasyyutikals) Republic of Moldova

  • Препарат Омепразол.

    Omeprazol

    Antiulcerous means. Inhibitors of "the proton pump".

    CJSC FP OBOLENSKOYE Russia

  • Препарат Фамотидин.

    Famotidine

    Antiulcerous drugs. Blockers histamine H2 receptors.

    Hemofarm, A.D. (A.D. Hemofarm) Serbia

  • Препарат Омепразол.

    Omeprazol

    Means for treatment of a round ulcer. Inhibitors of "the proton pump".

    Arterium (Arterium) Ukraine

  • Препарат Фамосан.

    Famosang

    Antiulcerous drugs. Blockers histamine H2 receptors.

    PRO.MED.CS Praha a.s. (Missile defense. MED.TSS, Prague, a.o.) Czech Republic


  • Сайт детского здоровья